Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 27 record(s)

Req # A-2022-00042

Please provide all documents in the possession of the Canadian Radio-television and Telecommunications Commission from January 1, 2014 to September 12, 2022 that relate to VOIP telephony providers.

Organization: Canadian Radio-television and Telecommunications Commission

124 page(s)
July 2023

Req # A-2022-00081

All records from January 1, 2023 to January 31, 2023 between the CRTC and representatives from: BCE Inc., Rogers Communications, Telus Corp., Shaw communications, and TekSavvy, related to: Wholesale internet access rates, mobile wireless prices, mobile virtual network operators, Huawei and ZTE, 5G, pole attachments, the Broadband Fund, and smaller ISPs being purchased by larger ones.

Organization: Canadian Radio-television and Telecommunications Commission

2 page(s)
July 2023

Req # A-2023-00009

Please provide a copy of all documents held by the CRTC from 1 January 2020 to May 17 2023, about a Canadian or non-Canadian online undertaking or undertakings, related to revenues, sales, expenditures, subscriptions, employment, hours tuned, and actual uploads and downloads.

Organization: Canadian Radio-television and Telecommunications Commission

0 page(s)
July 2023

Req # A-2023-00011

Please provide a copy of all documents dated from 1 November 2022 to 24 May 2023 regarding (a) the petitions filed with the Governor in Council (GIC) concerning Decision CRTC 2022-165, (b) the approach the CRTC may, could or will take regarding the reconsideration, and (c) Order Referring Back to the CRTC Broadcasting Decision 2022-165 SI/2022-44.

Organization: Canadian Radio-television and Telecommunications Commission

25 page(s)
July 2023

Req # A-2023-00022

Please provide all records relating to the "Canada is dying" documentary by Aaron Gunn, from May 1 2023 to June 16 2023.

Organization: Canadian Radio-television and Telecommunications Commission

0 page(s)
July 2023

Req # A-2023-00024

Please provide a copy of all documents from 2010 to 20 June 2023 which concern the decision to destroy the TV program logs the CRTC had received from broadcasters in the years before 1 January 2015.

Organization: Canadian Radio-television and Telecommunications Commission

2 page(s)
July 2023

Req # A-2023-00026

Please provide a copy of all documents, including any research, studies, analyses or data which refer to or address the effects, or the impact, or the functioning of the Journalistic Independence Code, approved by the CRTC in Broadcasting Public Notice 2008-5 and imposed as a standard condition of licence on certain programming services in Broadcasting Regulatory Policy 2016-436.

Organization: Canadian Radio-television and Telecommunications Commission

0 page(s)
July 2023

Req # A-2022-05111

Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on October 6, 2022, or any prior drafts or versions of those 2022 Guidelines (for example, if a draft version was circulated to Health Canada for comment in September 2022, it would be part of the “draft guidelines” for the purpose of this request). • Emails or other communications from Health Canada commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Emails or other communications from the Board members or Board Chair commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Any training presentations, training manuals, or summaries of the new guidelines prepared for use by the Board Staff, Board, or other governmental departments prepared between July 1, 2022, and October 6, 2022. • Any documents with calculations of how much prices will decrease under the draft guidelines, or under alternative pricing rules, and that were prepared between January 1, 2022, and October 6, 2022 (note the change in date relative to other requests). • Any documents comparing prices or price reductions under the draft guidelines and the old PMPRB Compendium of Guidelines and Procedures. • Any documents, including legal memos, on the compliance of the draft guidelines with legal decisions about the PMPRB, including Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2021 FCA 157, Merck Canada c Canada, 2022 QCCA 240, and Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725. • Any documents which discuss how a medicine’s therapeutic class and comparator products will be established under the draft guidelines. • Any documents showing how the Board Staff arrived at the exact pricing tests discussed in paragraph 33-35 of the draft Guidelines. • Any documents which discuss how Board Staff will assess whether a price is excessive *after* an investigation has been opened. For context, the backgrounder which accompanied the draft guidelines suggested that staff will consider “the totality of the circumstances surrounding the price of the medicine, through the lens of the section 85 factors.

Organization: Patented Medicine Prices Review Board Canada

197 page(s)
July 2023

Req # A-2023-025211

With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.

Organization: Patented Medicine Prices Review Board Canada

18 page(s)
July 2023

Req # A-2023-025599

For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be excessive? Of those that were found to be excessive, how many resulted in orders to reduce the prescription price?

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
July 2023
Date modified: